In this regard, the main targeting components of DNA repair machinery such as RAD51, XRCC3, RPA‐1 in HR and XRCC4, KU70, KU80 in NHEJ can open a new window for treatment of the EC by sensitizing tumor cells to radiotherapy. This evidence concerns the gene XRCC5 and neoplasm.